Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

Published on Jan 4, 2021in Nature Genetics27.603
· DOI :10.1038/S41588-020-00748-0
David V. Conti72
Estimated H-index: 72
(SC: University of Southern California),
Burcu F. Darst5
Estimated H-index: 5
(SC: University of Southern California)
+ 228 AuthorsChristopher A. Haiman113
Estimated H-index: 113
(SC: University of Southern California)
Sources
Abstract
Prostate cancer is a highly heritable disease with large disparities in incidence rates across ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants. The top genetic risk score (GRS) decile was associated with odds ratios that ranged from 5.06 (95% confidence interval (CI), 4.84-5.29) for men of European ancestry to 3.74 (95% CI, 3.36-4.17) for men of African ancestry. Men of African ancestry were estimated to have a mean GRS that was 2.18-times higher (95% CI, 2.14-2.22), and men of East Asian ancestry 0.73-times lower (95% CI, 0.71-0.76), than men of European ancestry. These findings support the role of germline variation contributing to population differences in prostate cancer risk, with the GRS offering an approach for personalized risk prediction.
📖 Papers frequently viewed together
References78
Newest
#1Laramie E. Duncan (Stanford University)H-Index: 29
#2Hanyang Shen (Stanford University)H-Index: 11
Last. Benjamin W. Domingue (Stanford University)H-Index: 24
view all 8 authors...
A historical tendency to use European ancestry samples hinders medical genetics research, including the use of polygenic scores, which are individual-level metrics of genetic risk. We analyze the first decade of polygenic scoring studies (2008–2017, inclusive), and find that 67% of studies included exclusively European ancestry participants and another 19% included only East Asian ancestry participants. Only 3.8% of studies were among cohorts of African, Hispanic, or Indigenous peoples. We find ...
248 CitationsSource
#1Jonathan Marchini (University of Oxford)H-Index: 68
#1Clare Bycroft (University of Oxford)H-Index: 6
Last. Peter Donnelly (University of Oxford)H-Index: 120
view all 19 authors...
The UK Biobank project is a prospective cohort study with deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment. The open resource is unique in its size and scope. A rich variety of phenotypic and health-related information is available on each participant, including biological measurements, lifestyle indicators, biomarkers in blood and urine, and imaging of the body and brain. Follow-up information i...
1,882 CitationsSource
#1Fredrick R. Schumacher (Case Western Reserve University)H-Index: 77
#2Ali Amin Al Olama (University of Cambridge)H-Index: 34
Last. Rosalind A. EelesH-Index: 112
view all 187 authors...
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 × 10−9; T>G, p.Val109Gly...
302 CitationsSource
#1Tokhir DadaevH-Index: 22
#1Tokhir DadaevH-Index: 3
Last. Zsofia Kote-JaraiH-Index: 61
view all 310 authors...
Prostate cancer is a polygenic disease with a large heritable component. A number of common, low-penetrance prostate cancer risk loci have been identified through GWAS. Here we apply the Bayesian multivariate variable selection algorithm JAM to fine-map 84 prostate cancer susceptibility loci, using summary data from a large European ancestry meta-analysis. We observe evidence for multiple independent signals at 12 regions and 99 risk signals overall. Only 15 original GWAS tag SNPs remain among t...
51 CitationsSource
#1Samuel A. Lambert (U of T: University of Toronto)H-Index: 11
#2Arttu Jolma (U of T: University of Toronto)H-Index: 14
Last. Matthew T. Weirauch (University of Cincinnati Academic Health Center)H-Index: 38
view all 10 authors...
Transcription factors (TFs) recognize specific DNA sequences to control chromatin and transcription, forming a complex system that guides expression of the genome. Despite keen interest in understanding how TFs control gene expression, it remains challenging to determine how the precise genomic binding sites of TFs are specified and how TF binding ultimately relates to regulation of transcription. This review considers how TFs are identified and functionally characterized, principally through th...
831 CitationsSource
#1David V. Conti (SC: University of Southern California)H-Index: 72
#2Kan Wang (SC: University of Southern California)H-Index: 3
Last. PracticalH-Index: 3
view all 89 authors...
Prostate cancer incidence is 1.6-fold higher in African Americans than in other populations. The risk factors that drive this disparity are unknown and potentially consist of social, environmental, and genetic influences. To investigate the genetic basis of prostate cancer in men of African ancestry, we performed a genome-wide association meta-analysis using two-sided statistical tests in 10 202 case subjects and 10 810 control subjects. We identified novel signals on chromosomes 13q34 and 22q12...
36 CitationsSource
#1Karoline B. Kuchenbaecker (University of Cambridge)H-Index: 27
#2Lesley McGuffog (University of Cambridge)H-Index: 47
Last. Antonis C. Antoniou (University of Cambridge)H-Index: 83
view all 21 authors...
Background: Genome-wide association studies (GWAS) have identified 94 common single-nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk and 18 associated with ovarian cancer (OC) risk. Several of these are also associated with risk of BC or OC for women who carry a pathogenic mutation in the high-risk BC and OC genes BRCA1 or BRCA2. The combined effects of these variants on BC or OC risk for BRCA1 and BRCA2 mutation carriers have not yet been assessed while their clinical man...
137 CitationsSource
#1Shenglin Mei (Tongji University)H-Index: 15
#2Qian Qin (Tongji University)H-Index: 12
Last. X. Shirley LiuH-Index: 90
view all 14 authors...
Chromatin immunoprecipitation, DNase I hypersensitivity and transposase-accessibility assays combined with high-throughput sequencing enable the genome-wide study of chromatin dynamics, transcription factor binding and gene regulation. Although rapidly accumulating publicly available ChIP-seq, DNase-seq and ATAC-seq data are a valuable resource for the systematic investigation of gene regulation processes, a lack of standardized curation, quality control and analysis procedures have hindered ext...
252 CitationsSource
#1Sayantan Das (UM: University of Michigan)H-Index: 17
#2Lukas Forer (Innsbruck Medical University)H-Index: 19
Last. Christian Fuchsberger (UM: University of Michigan)H-Index: 53
view all 21 authors...
Christian Fuchsberger, Goncalo Abecasis and colleagues describe a new web-based imputation service that enables rapid imputation of large numbers of samples and allows convenient access to large reference panels of sequenced individuals. Their state space reduction provides a computationally efficient solution for genotype imputation with no loss in imputation accuracy.
1,279 CitationsSource
#1Halit Ongen (Swiss Institute of Bioinformatics)H-Index: 32
#2Alfonso Buil (Swiss Institute of Bioinformatics)H-Index: 34
Last. Olivier Delaneau (Swiss Institute of Bioinformatics)H-Index: 34
view all 5 authors...
In order to discover quantitative trait loci, multi-dimensional genomic datasets combining DNA-seq and ChiP-/RNA-seq require methods that rapidly correlate tens of thousands of molecular phenotypes with millions of genetic variants while appropriately controlling for multiple testing.
242 CitationsSource
Cited By22
Newest
#1Xilin Jiang (University of Oxford)
#2Christopher Holmes (The Turing Institute)H-Index: 63
Last. Gil McVean (University of Oxford)H-Index: 57
view all 0 authors...
Inherited genetic variation contributes to individual risk for many complex diseases and is increasingly being used for predictive patient stratification. Previous work has shown that genetic factors are not equally relevant to human traits across age and other contexts, though the reasons for such variation are not clear. Here, we introduce methods to infer the form of the longitudinal relationship between genetic relative risk for disease and age and to test whether all genetic risk factors be...
Source
#1Yiliang Zhang (Yale University)H-Index: 1
#2Youshu Cheng (Yale University)H-Index: 1
Last. Hongyu Zhao (Yale University)H-Index: 97
view all 0 authors...
With the increasing accessibility of individual-level data from genome wide association studies, it is now common for researchers to have individual-level data of some traits in one specific population. For some traits, we can only access public released summary-level data due to privacy and safety concerns. The current methods to estimate genetic correlation can only be applied when the input data type of the two traits of interest is either both individual-level or both summary-level. When res...
Source
#1Minh-Phuong Huynh-Le (UCSD: University of California, San Diego)H-Index: 10
#2Roshan Karunamuni (UCSD: University of California, San Diego)H-Index: 15
Last. Artitaya Lophatananon (University of Manchester)H-Index: 31
view all 0 authors...
Introduction: Prostate cancer risk stratification using single-nucleotide polymorphisms (SNPs) demonstrates considerable promise in men of European, Asian, and African genetic ancestries, but there is still need for increased accuracy. We evaluated whether including additional SNPs in a prostate cancer polygenic hazard score (PHS) would improve associations with clinically significant prostate cancer in multi-ancestry datasets. Methods: In total, 299 SNPs previously associated with prostate canc...
Source
#1Manato Kanesaka (Chiba University)H-Index: 3
#2Shinichi Sakamoto (Chiba University)H-Index: 21
Last. Yuzuru Ikehara (Chiba University)H-Index: 43
view all 12 authors...
Abstract null null Background null To identify the real high-risk group among Japanese de novo metastatic prostate cancer patients who fit CHAARTED or LATITUDE criteria. null null null Methods null We retrospectively studied patients who fitted CHAARTED (292 patients) and LATITUDE (294 patients) criteria from Japanese multi-institutions. All patients received androgen deprivation therapy with bicalutamide as an initial treatment. Factors related to overall survival (OS) and progression-free surv...
Source
#1Charlotte SalmonH-Index: 1
Last. Janet L. Stanford (Fred Hutchinson Cancer Research Center)H-Index: 98
view all 27 authors...
Source
#1Mnaya Y. Mavura (UCSF: University of California, San Francisco)
#2Franklin W. Huang (UCSF: University of California, San Francisco)H-Index: 25
Disparities in cancer incidence, prevalence, burden, and outcome exist among specific population groups in the United States. Researchers have identified germline genetic risk single-nucleotide polymorphisms (SNP) that differ by ancestry and may contribute to some of these differences. In this issue of Cancer Research, Han and colleagues found the prostate cancer risk SNP rs4713266 is associated with increased risk of patients with African ancestry. The authors investigated the functional role o...
Source
#1Sarah BenafifH-Index: 5
Last. Anthony ChamberlainH-Index: 4
view all 30 authors...
Objectives null To assess the feasibility and uptake of a community based prostate cancer (PrCa) screening programme selecting men according to their genetic risk of PrCa. To assess the uptake of PrCa screening investigations by men invited for screening. The uptake of the pilot study would guide the opening of the larger BARCODE1 study recruiting 5000 men. null Subjects and methods null Healthy males aged 55-69 years were invited to participate via their General Practitioners (GPs). Saliva samp...
Source
#1Jianfeng Xu (NorthShore University HealthSystem)H-Index: 107
#2William B. Isaacs (Johns Hopkins University)H-Index: 133
Last. Christian P. Pavlovich (Johns Hopkins University)H-Index: 51
view all 16 authors...
Background Prostate cancer (PCa) is characterized by its tendency to be multifocal. However, few studies have investigated the endogenous factors that explain the multifocal disease. The primary objective of the current study is to test whether inherited PCa risk is associated with multifocal tumors in PCa patients. Methods Subjects in this study were PCa patients of European ancestry undergoing active surveillance at Johns Hopkins Hospital (N = 805) and NorthShore University HealthSystem (N = 4...
1 CitationsSource
#1Aniket Shetty (University of Cambridge)H-Index: 6
#2Ji Hae Seo (Harvard University)H-Index: 26
Last. Alexander Gusev (Broad Institute)H-Index: 34
view all 7 authors...
Background: Genome-wide association studies of prostate cancer have identified >250 significant risk loci, but the causal variants and mechanisms for these loci remain largely unknown. Here, we sought to identify and characterize risk harboring regulatory elements by integrating epigenomes from primary prostate tumor and normal tissues of 27 patients across the H3K27ac, H3K4me3, and H3K4me2 histone marks and FOXA1 and HOXB13 transcription factors. Results: We identified 7,371 peaks with signific...
Source
#1Maeve Kiely (NIH: National Institutes of Health)H-Index: 1
Despite substantial improvements in cancer survival, not all population groups have benefitted equally from this progress. For prostate cancer, men of African descent in the United States and England continue to have about double the rate of fatal disease compared to other men. Studies suggest that when there is equal access to care, survival disparities are greatly diminished. However, notable differences exist in prostate tumor biology across population groups. Ancestral factors and disparate ...
Source